MAP1LC3A and type 2 diabetes mellitus: In leukocytes from T2D patients treated with SS-31, this trend was also accompanied by a significant reduction of protein expression of distinct markers of autophagy such as Beclin1 and the ratio of LC3 II/I (Figure 3B,C; p < 0.05).